You are here

Article info

Article menu
Download PDFPDF
Letter
Biologics, spondylitis and COVID-19

Authors

  1. Correspondence to Dr James Todd Rosenbaum, Casey Eye Institute, Oregon Health and Science University, Portland, OR 97239, USA; rosenbaj{at}ohsu.edu
View Full Text

Citation

Rosenbaum JT, Hamilton H, Choi D, et al
Biologics, spondylitis and COVID-19
Annals of the Rheumatic Diseases 2020;79:1663-1665.

Publication history

  • Received May 13, 2020
  • Revised May 21, 2020
  • Accepted May 22, 2020
  • First published June 10, 2020.
Online issue publication 
May 12, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage